Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


To Russia, With Love: Selecta, BIND To Create Subsidiaries In Financing Deals With Rusnano

This article was originally published in PharmAsia News

Executive Summary

Selecta Biosciences Inc. and BIND Biosciences Inc., two Boston-based -- and heretofore low-profile -- young biotechs, have raised a combined $94.5 million from a mix of equity financings and strategic alliances with one of the world's largest investment funds dedicated to nanotechnology, Rusnano, and other investors

You may also be interested in...

Russia's First BioPharma Public-Private Partnership Eyes Bio-Betters, Attracts $110 Million

Russia's bid to catch up in the global race to establish a recognized biopharma sector picked up speed with the Aug. 4 announcement of SynBio, a $110 million joint venture to develop bio-betters and innovative medicines for the Russian and international markets

Selecta To Perform Preclinical Malaria Vaccine Work For SAIC

Biotech will combine its SVP platform technology with a SAIC-developed antigen to try to find the key to treating malaria.

In Oncology Drug Boom, Can Next-Gen Cytotoxics Fit In?

The drug industry has placed a bull's eye on the field of oncology as a key therapeutic area, but not all oncology players are created equal.

Related Content

Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts